Cargando…
Human Vaccines & Immunotherapeutics: News
Therapeutic HIV vaccine promising in the clinic GAVI aims to immunize 30 million against HPV by 2020 Self-destructing Salmonella to deliver oral DNA vaccines Novel strategy for vaccine design: Enzymatically modified antibodies GSK’s four-strain seasonal influenza vaccine approved in the US MVA85A TB...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859739/ https://www.ncbi.nlm.nih.gov/pubmed/23449312 http://dx.doi.org/10.4161/hv.24056 |
| _version_ | 1782295457949548544 |
|---|---|
| author | Riedmann, Eva M. |
| author_facet | Riedmann, Eva M. |
| author_sort | Riedmann, Eva M. |
| collection | PubMed |
| description | Therapeutic HIV vaccine promising in the clinic GAVI aims to immunize 30 million against HPV by 2020 Self-destructing Salmonella to deliver oral DNA vaccines Novel strategy for vaccine design: Enzymatically modified antibodies GSK’s four-strain seasonal influenza vaccine approved in the US MVA85A TB vaccine tested in newborns of HIV-positive mothers Use of oral cholera vaccines promoted GSK partners with Vodafone to increase childhood vaccinatin in Mozambique |
| format | Online Article Text |
| id | pubmed-3859739 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | Landes Bioscience |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-38597392013-12-16 Human Vaccines & Immunotherapeutics: News Riedmann, Eva M. Hum Vaccin Immunother News, Policy & Profiles Therapeutic HIV vaccine promising in the clinic GAVI aims to immunize 30 million against HPV by 2020 Self-destructing Salmonella to deliver oral DNA vaccines Novel strategy for vaccine design: Enzymatically modified antibodies GSK’s four-strain seasonal influenza vaccine approved in the US MVA85A TB vaccine tested in newborns of HIV-positive mothers Use of oral cholera vaccines promoted GSK partners with Vodafone to increase childhood vaccinatin in Mozambique Landes Bioscience 2013-02-01 2013-02-01 /pmc/articles/PMC3859739/ /pubmed/23449312 http://dx.doi.org/10.4161/hv.24056 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
| spellingShingle | News, Policy & Profiles Riedmann, Eva M. Human Vaccines & Immunotherapeutics: News |
| title | Human Vaccines & Immunotherapeutics: News |
| title_full | Human Vaccines & Immunotherapeutics: News |
| title_fullStr | Human Vaccines & Immunotherapeutics: News |
| title_full_unstemmed | Human Vaccines & Immunotherapeutics: News |
| title_short | Human Vaccines & Immunotherapeutics: News |
| title_sort | human vaccines & immunotherapeutics: news |
| topic | News, Policy & Profiles |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859739/ https://www.ncbi.nlm.nih.gov/pubmed/23449312 http://dx.doi.org/10.4161/hv.24056 |
| work_keys_str_mv | AT riedmannevam humanvaccinesimmunotherapeuticsnews |